News

News Feed

News

Disease
Functional Domain
Type
Source
Reset filters

3069 results

What Anthropic’s latest AI discovery does—and doesn’t—show

This story originally appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in your inbox first, sign up here. Anthropic—currently the world’s most valuable AI company, with a nearly $1 trillion valuation—has a reputation for publishing…

Tags: Academic research, Government / public service

Read more

The Download: a donor conception cap and world models for AI

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Sperm donors need limits, says a European fertility group Ties van der Meer doesn’t know how…

Tags: Australia, European Union, Healthcare provider, Motor and impulse regulation, Substance use

Read more

Diagnostic redirection in dementia-first spinocerebellar ataxia type 17: a family-based case report and focused literature review

BackgroundSpinocerebellar ataxia type 17 (SCA17) is an autosomal dominant repeat-expansion disorder with marked phenotypic heterogeneity. Cognitive and neuropsychiatric symptoms may dominate early recognition and initially suggest a primary dementia syndrome. We aimed to illustrate diagnostic redirection in dementia-first SCA17 through…

Tags: None

Read more

Nucleus accumbens DRD2 receptor agonism attenuates escape behavior

Animals learn to approach and escape stimuli in their environment, in part through the representation of rewarding or aversive outcomes in the nucleus accumbens (NAc). The regulation of reward motivation in the NAc by dopamine signaling at DRD1 and DRD2…

Tags: Academic research, Body-focused and impulse habits, Fear and threat response, Medication

Read more

Attention-deficit/hyperactivity disorder and chronic pain: a scoping review of epidemiology, clinical phenotypes, mechanisms, and treatment

IntroductionEmerging evidence suggests a potential association between attention-deficit/hyperactivity disorder (ADHD) and chronic pain; however, extant findings are dispersed across disciplines and have not yet been comprehensively synthesized. This scoping review aimed to systematically map the epidemiological evidence, clinical phenotypes, proposed…

Tags: Academic research, ADHD, Cognitive focus and executive control, Medication, Sexual drive and regulation

Read more

Family caregivers’ involvement in home-based recovery for patients with schizophrenia: a qualitative study in Beijing, China

BackgroundFamily caregivers play critical roles in supporting the home-based recovery of patients with schizophrenia, but they often encounter substantial challenges and receive insufficient systemic support. Understanding caregivers’ involvement in home-based recovery is essential for aligning community mental health services with…

Tags: Academic research, Medication, Mental health, Schizophrenia spectrum

Read more

Intracranial hypertension after MECT: successful transition to rTMS for refractory auditory hallucinations: a case report

A 21-year-old female patient with schizophrenia, whose primary symptom was refractory auditory hallucinations, developed intracranial hypertension syndrome following her first session of modified electroconvulsive therapy (MECT), presenting with severe headache, projectile vomiting, diplopia and meningeal signs. She subsequently received 1 Hz…

Tags: Schizophrenia spectrum

Read more

An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial

Nature Medicine, Published online: 13 July 2026; doi:10.1038/s41591-026-04518-zIn a phase 1 trial, treatment with the antibody−drug conjugate DYP688, targeting PMEL and delivering a Gq/11 inhibitor, in patients with GNAQ/GNA11-mutant metastatic uveal melanoma or other GNAQ/GNA11-mutant melanomas, showed acceptable safety and…

Tags: Biomarker, Clinical trial

Read more

News Feed

News

Disease
Functional Domain
Type
Source
Reset filters

3069 results

What Anthropic’s latest AI discovery does—and doesn’t—show

This story originally appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in your inbox first, sign up here. Anthropic—currently the world’s most valuable AI company, with a nearly $1 trillion valuation—has a reputation for publishing…

Tags: Academic research, Government / public service

Read more

The Download: a donor conception cap and world models for AI

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Sperm donors need limits, says a European fertility group Ties van der Meer doesn’t know how…

Tags: Australia, European Union, Healthcare provider, Motor and impulse regulation, Substance use

Read more

Diagnostic redirection in dementia-first spinocerebellar ataxia type 17: a family-based case report and focused literature review

BackgroundSpinocerebellar ataxia type 17 (SCA17) is an autosomal dominant repeat-expansion disorder with marked phenotypic heterogeneity. Cognitive and neuropsychiatric symptoms may dominate early recognition and initially suggest a primary dementia syndrome. We aimed to illustrate diagnostic redirection in dementia-first SCA17 through…

Tags: None

Read more

Nucleus accumbens DRD2 receptor agonism attenuates escape behavior

Animals learn to approach and escape stimuli in their environment, in part through the representation of rewarding or aversive outcomes in the nucleus accumbens (NAc). The regulation of reward motivation in the NAc by dopamine signaling at DRD1 and DRD2…

Tags: Academic research, Body-focused and impulse habits, Fear and threat response, Medication

Read more

Attention-deficit/hyperactivity disorder and chronic pain: a scoping review of epidemiology, clinical phenotypes, mechanisms, and treatment

IntroductionEmerging evidence suggests a potential association between attention-deficit/hyperactivity disorder (ADHD) and chronic pain; however, extant findings are dispersed across disciplines and have not yet been comprehensively synthesized. This scoping review aimed to systematically map the epidemiological evidence, clinical phenotypes, proposed…

Tags: Academic research, ADHD, Cognitive focus and executive control, Medication, Sexual drive and regulation

Read more

Family caregivers’ involvement in home-based recovery for patients with schizophrenia: a qualitative study in Beijing, China

BackgroundFamily caregivers play critical roles in supporting the home-based recovery of patients with schizophrenia, but they often encounter substantial challenges and receive insufficient systemic support. Understanding caregivers’ involvement in home-based recovery is essential for aligning community mental health services with…

Tags: Academic research, Medication, Mental health, Schizophrenia spectrum

Read more

Intracranial hypertension after MECT: successful transition to rTMS for refractory auditory hallucinations: a case report

A 21-year-old female patient with schizophrenia, whose primary symptom was refractory auditory hallucinations, developed intracranial hypertension syndrome following her first session of modified electroconvulsive therapy (MECT), presenting with severe headache, projectile vomiting, diplopia and meningeal signs. She subsequently received 1 Hz…

Tags: Schizophrenia spectrum

Read more

An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial

Nature Medicine, Published online: 13 July 2026; doi:10.1038/s41591-026-04518-zIn a phase 1 trial, treatment with the antibody−drug conjugate DYP688, targeting PMEL and delivering a Gq/11 inhibitor, in patients with GNAQ/GNA11-mutant metastatic uveal melanoma or other GNAQ/GNA11-mutant melanomas, showed acceptable safety and…

Tags: Biomarker, Clinical trial

Read more